Glaukos Corporation
(GKOS - NYSE)
121,66 USD
📋 Profilo Aziendale

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

|